Company research
BIOLARGO, INC.
CIK 880242Updated Sep 29, 2026
SecurityBLGO · OTC · equity
Name history
NUWAY MEDICAL INC · through Apr 3, 2007NUWAY ENERGY INC · through Feb 5, 2003LATIN AMERICAN CASINOS INC · through Feb 15, 2001
BLGO price & chart
Loading TradingView…
OTC:BLGO on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Regulation FD Disclosure
Items 7.01, 9.01
Regulation FD Disclosure
Items 7.01, 9.01
10-Q filing
10-Q filing
Regulation FD Disclosure
Items 7.01, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 8,311,000Source | 10,513,000Source | 8,205,000Source | 4,858,000Source |
| Property, Plant and Equipment, NetUSD | 1,643,000Source | 1,742,000Source | 662,000Source | 287,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 3,883,000Source | 3,548,000Source | 3,539,000Source | 1,851,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 615,000Source | 3,168,000Source | 2,612,000Source | 1,064,000Source |
| Inventory, NetUSD | 310,000Source | 330,000Source | 153,000Source | 120,000Source |
| Assets, CurrentUSD | 5,114,000Source | 7,137,000Source | 6,362,000Source | 3,153,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 306,000Source | 91,000Source | 58,000Source | 118,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,028,000Source | 992,000Source | 1,092,000Source | 867,000Source |
| Other Assets, NoncurrentUSD | 106,000Source | 95,000Source | 70,000Source | 124,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 6,785,000Source | 4,457,000Source | 4,003,000Source | 2,847,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 213,000Source | 202,000Source | 196,000Source | 186,000Source |
| Additional Paid in CapitalUSD | 165,316,000Source | 158,332,000Source | 154,023,000Source | 148,435,000Source |
| Retained Earnings (Accumulated Deficit)USD | -161,280,000Source | -149,500,000Source | -147,098,000Source | -143,594,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -207,000Source | -183,000Source | -277,000Source | -149,000Source |
| Stockholders' Equity Attributable to ParentUSD | 4,042,000Source | 8,851,000Source | 6,844,000Source | 4,878,000Source |
| Liabilities and EquityUSD | 8,311,000Source | 10,513,000Source | 8,205,000Source | 4,858,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 5,063,000Source | 2,648,000Source | 2,710,000Source | 1,576,000Source |
| Operating Lease, Liability, CurrentUSD | 210,000Source | 105,000Source | 105,000Source | 97,000Source |
| Accounts Payable, CurrentUSD | 1,012,000Source | 826,000Source | 1,212,000Source | 717,000Source |
| Operating Lease, Liability, NoncurrentUSD | 864,000Source | 922,000Source | 1,004,000Source | 773,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -2,516,000Source | -2,795,000Source | -2,642,000Source | -2,867,000Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | 0Source | 0Source | 0Source | — |
| Dividends PayableUSD | 347,000Source | 345,000Source | — | — |
| Long-term Debt, Current MaturitiesUSD | — | 552,000Source | — | 100,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | 289,000Source | 237,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -15,189,000Source | -4,347,000Source | -4,648,000Source | -5,132,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 2,965,000Source | 2,063,000Source | 2,124,000Source | 2,071,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 1,814,000Source | 569,000Source | 1,633,000Source | 551,000Source |
| Increase (Decrease) in InventoriesUSD | -20,000Source | 177,000Source | 89,000Source | 35,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -8,297,000Source | -3,206,000Source | -2,365,000Source | -2,762,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 435,000Source | -1,317,000Source | -478,000Source | -271,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 8,221,000Source | 4,438,000Source | 4,659,000Source | 3,956,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 335,000Source | 9,000Source | 1,688,000Source | 889,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 344,000Source | 33,000Source | 58,000Source | 36,000Source |
| Additional Financial Items | ||||
| Amortization of Debt Issuance Costs and DiscountsUSD | 196,000Source | 0Source | 3,000Source | 17,000Source |
| DepreciationUSD | 145,000Source | 155,000Source | 103,000Source | — |
| Dividends PayableUSD | 347,000Source | 345,000Source | — | — |
| Income (Loss) from Equity Method InvestmentsUSD | -14,000Source | -5,000Source | -14,000Source | -15,000Source |
| Income Tax Expense (Benefit)USD | — | 0Source | — | — |
| InterestExpenseNonoperatingUSD | 540,000Source | — | — | — |
| Inventory Write-downUSD | — | 0Source | 54,000Source | 158,000Source |
| Investment Income, InterestUSD | 200,000Source | 33,000Source | — | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -3,409,000Source | -1,945,000Source | -1,144,000Source | -659,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -11,780,000Source | -2,402,000Source | -3,504,000Source | -4,473,000Source |
| Nonoperating Income (Expense)USD | -334,000Source | -16,000Source | — | — |
| Operating ExpensesUSD | 18,261,000Source | 12,184,000Source | 10,734,000Source | 8,247,000Source |
| Operating Lease, ExpenseUSD | 404,000Source | 365,000Source | 335,000Source | 316,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -68,000Source | 258,000Source |
| Proceeds from Issuance of Common StockUSD | 2,027,000Source | 594,000Source | 2,153,000Source | 3,617,000Source |
| Proceeds from Stock Options ExercisedUSD | 0Source | 153,000Source | 0Source | 40,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 7,765,000Source | 17,779,000Source | 12,230,000Source | 5,884,000Source |
| Stock or Unit Option Plan ExpenseUSD | 2,965,000Source | 2,063,000Source | 1,864,000Source | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | — | — | 12,230,000Source | — |
| Cost of RevenueUSD | 4,359,000Source | 9,926,000Source | 6,076,000Source | 3,027,000Source |
| Selling, General and Administrative ExpenseUSD | 11,768,000Source | 9,302,000Source | 8,058,000Source | 6,731,000Source |
| Operating Income (Loss)USD | -14,855,000Source | -4,331,000Source | -4,580,000Source | -5,390,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -68,000Source | 258,000Source |
| Income Tax Expense (Benefit)USD | — | 0Source | — | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -3,409,000Source | -1,945,000Source | -1,144,000Source | -659,000Source |
| Earnings Per Share, BasicUSD per share | -0.04Source | -0.01Source | -0.02Source | -0.02Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 306,954,778Source | 298,122,239Source | 285,956,852Source | 268,302,234Source |
| Interest Expense (non-operating)USD | 540,000Source | — | — | — |
| Additional Financial Items | ||||
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 103,000Source | 45,000Source |
| Gross ProfitUSD | 3,406,000Source | 7,853,000Source | 6,154,000Source | 2,857,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -14,661,000Source | — | — | — |
| Income (Loss) from Equity Method InvestmentsUSD | -14,000Source | -5,000Source | -14,000Source | -15,000Source |
| Interest ExpenseUSD | — | — | 91,000Source | 53,000Source |
| Interest Expense, DebtUSD | 540,000Source | 66,000Source | 91,000Source | 53,000Source |
| Interest Income (Expense), NetUSD | -340,000Source | -33,000Source | -91,000Source | — |
| Interest Income (Expense), Nonoperating, NetUSD | — | -33,000Source | — | — |
| Investment Income, InterestUSD | 200,000Source | 33,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -11,780,000Source | -2,402,000Source | -3,504,000Source | -4,473,000Source |
| Nonoperating Income (Expense)USD | -334,000Source | -16,000Source | — | — |
| Operating ExpensesUSD | 18,261,000Source | 12,184,000Source | 10,734,000Source | 8,247,000Source |
| Operating Lease, ExpenseUSD | 404,000Source | 365,000Source | 335,000Source | 316,000Source |
| Research and Development ExpenseUSD | 2,593,000Source | 2,882,000Source | 2,282,000Source | 1,319,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 7,765,000Source | 17,779,000Source | 12,230,000Source | 5,884,000Source |
Offerings
Registration 333-294947
- Offering amount
- $0.15.
- Offering price
- market-price
- Ticker
- BLGO
Registration 333-294948
- Offering amount
- $0.15.
- Offering price
- market-price
- Ticker
- BLGO
Registration 333-278669
- Offering amount
- $0.205.
- Offering price
- market-price
- Ticker
- BLGO
Registration 333-268973
- Offering amount
- $0.23.
- Offering price
- market-price
- Ticker
- BLGO